switching from tirzepatide to semaglutide dosage chart Tirzepatide: Is It a Good Idea? Switching Semaglutide to Tirzepatide |

Patzelt C, Schiltz E

If a size shows as out of stock, you can reach our team directly to ask about expected restock timing or to be notified when your preferred size is available again

304 , C1053C1063 (2013)

If you want to review the current retatrutide option carried by Great Northern Peptides, start with the retatrutide product page

This may mean pausing treatment, switching to a lower-dose formulation, exploring alternative peptides, or reconsidering the medication class altogether

"Triple-Hormone-Receptor Agonist Retatrutide for Obesity." NEJM 2023;389:514526 FDA Prescription Drug User Fee Act (PDUFA) Guidelines FDA Center for Drug Evaluation and Research (CDER): NDA review process ClinicalTrials.gov: TRIUMPH Phase 3 program trial registry Historical obesity drug approval precedents: Semaglutide, Tirzepatide, Liraglutide Frequently Asked Questions Based on the current timeline, retatrutide FDA approval is expected in late 2027 to Q1 2028